Average Co-Inventor Count = 6.24
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Korea Institute of Science and Technology (8 from 2,173 patents)
2. Industry-University Cooperation Foundation Hanyang University (1 from 1,129 patents)
3. Daegu-Gyeongbuk Medical Innovation Foundation (1 from 8 patents)
4. Pharos Ibio Co., Ltd. (2 patents)
8 patents:
1. 12466812 - Pyridinyltriazine derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, ameliorating, or treating cancer comprising same
2. 10647685 - Anti-inflammatory 6-phenoxypyrimidine derivatives, process for their preparation and pharmaceutical composition containing them
3. 10494346 - Substituted pyrimidine-4-carboxylic acids having anticancer activity
4. 10442796 - 2,3,5-substituted thiophene compound as protein kinase inhibitor
5. 10155767 - Therapeutic agent of acute myeloid leukemia containing 1,3,7-trisubstituted 3,4-dihydropyrimido[4,5-D]pyrimidine-2(1H)-one derivatives
6. 10130631 - CML therapeutic agents with reduced drug-resistance and side-effect comprising 1,6-disubstituted indole compounds
7. 10059717 - Urea compounds containing 3,4-dihydropyrimido[4,5-D]pyrimidin-2(1H)-one skeleton as protein kinase inhibitors
8. 9586936 - Heteroarylamine derivatives as protein kinase inhibitors